BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Wen X, Wang L, Sun X, Ma H, Fu Z, Li L. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer. Surg Oncol 2017;26:527-34. [PMID: 29113674 DOI: 10.1016/j.suronc.2017.09.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
2 Abbaszadegan MR, Taghehchian N, Aarabi A, Moghbeli M. MAEL Cancer-Testis Antigen as a Diagnostic Marker in Primary Stages of Gastric Cancer with Helicobacter pylori Infection. J Gastrointest Cancer 2020;51:17-22. [PMID: 30488287 DOI: 10.1007/s12029-018-0183-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Panduro-correa V, Dámaso-mata B, Loza-munárriz C, Herrera-matta J, Arteaga-livias K. Comparación de gastrectomía abierta frente a laparoscópica en cáncer gástrico avanzado. Revista de Gastroenterología de México 2020;85:32-41. [DOI: 10.1016/j.rgmx.2019.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 De Raffele E, Mirarchi M, Cuicchi D, Lecce F, Cola B. Evolving role of FDG-PET/CT in prognostic evaluation of resectable gastric cancer. World J Gastroenterol 2017; 23(38): 6923-6926 [PMID: 29097864 DOI: 10.3748/wjg.v23.i38.6923] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Wu M, Wang Y, Liu H, Song J, Ding J. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer. Biosci Rep 2020;40:BSR20193308. [PMID: 32338286 DOI: 10.1042/BSR20193308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chakrabarti J, Holokai L, Syu L, Steele N, Chang J, Dlugosz A, Zavros Y. Mouse-Derived Gastric Organoid and Immune Cell Co-culture for the Study of the Tumor Microenvironment. Methods Mol Biol 2018;1817:157-68. [PMID: 29959712 DOI: 10.1007/978-1-4939-8600-2_16] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
7 Zavros Y. Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells. Cell Mol Gastroenterol Hepatol. 2017;4:55-63. [PMID: 28560289 DOI: 10.1016/j.jcmgh.2017.03.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
8 Chakrabarti J, Holokai L, Syu L, Steele NG, Chang J, Wang J, Ahmed S, Dlugosz A, Zavros Y. Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer. Oncotarget 2018;9:37439-57. [PMID: 30647844 DOI: 10.18632/oncotarget.26473] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
9 Luo F, Wang Z, Chen S, Luo Z, Wang G, Yang H, Tang L, Raju N. DOK5 as a Prognostic Biomarker of Gastric Cancer Immunoinvasion: A Bioinformatics Analysis. BioMed Research International 2022;2022:1-22. [DOI: 10.1155/2022/9914778] [Reference Citation Analysis]
10 Zhang X, Ning Y, Xiao Y, Duan H, Qu G, Liu X, Du Y, Jiang D, Zhou J. MAEL contributes to gastric cancer progression by promoting ILKAP degradation. Oncotarget 2017;8:113331-44. [PMID: 29371914 DOI: 10.18632/oncotarget.22970] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
11 Huang XX, Zhang Q, Hu H, Jin Y, Zeng AL, Xia YB, Xu L. A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p. J Cell Biochem. 2020;. [PMID: 31898357 DOI: 10.1002/jcb.29641] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
12 Di Giorgio C, Marchianò S, Marino E, Biagioli M, Roselli R, Bordoni M, Bellini R, Urbani G, Zampella A, Distrutti E, Donini A, Graziosi L, Fiorucci S. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis. Front Oncol 2022;12:939969. [DOI: 10.3389/fonc.2022.939969] [Reference Citation Analysis]
13 Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. Int J Mol Sci 2020;21:E9400. [PMID: 33321820 DOI: 10.3390/ijms21249400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu Y, Hu G, Wu R, Gong N. High expression of miR-135b predicts malignant transformation and poor prognosis of gastric cancer. Life Sci 2020;257:118133. [PMID: 32710946 DOI: 10.1016/j.lfs.2020.118133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 Peng D, Cheng YX, Zhang W. Does Roux-en-Y Construction Really Bring Benefit of Type 2 Diabetes Mellitus Remission After Gastrectomy in Patients with Gastric Cancer?Diabetes Ther. 2020;11:2863-2872. [PMID: 33006131 DOI: 10.1007/s13300-020-00934-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yang C, Shi Y, Xie S, Chen J, Zhao Y, Qian F, Hao Y, Tang B, Yu P. Short-term outcomes of robotic- versus laparoscopic-assisted Total Gastrectomy for advanced gastric Cancer: a propensity score matching study. BMC Cancer 2020;20:669. [PMID: 32680479 DOI: 10.1186/s12885-020-07160-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Steele NG, Chakrabarti J, Wang J, Biesiada J, Holokai L, Chang J, Nowacki LM, Hawkins J, Mahe M, Sundaram N, Shroyer N, Medvedovic M, Helmrath M, Ahmad S, Zavros Y. An Organoid-Based Preclinical Model of Human Gastric Cancer. Cell Mol Gastroenterol Hepatol 2019;7:161-84. [PMID: 30522949 DOI: 10.1016/j.jcmgh.2018.09.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
18 Akl MF, Ibrahem MA, Khater A, El-Zahaf E, Farag K, Abdallah H. Etiologic and Clinicopathological Correlates of Gastric Carcinoma in the Egyptian Delta. Indian J Surg Oncol 2018;9:472-6. [PMID: 30538374 DOI: 10.1007/s13193-018-0754-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Lee TC, Wima K, Morris MC, Johnston ME, Shah SA, Ahmad SA, Patel SH, Wilson GC. Lack of National Adoption of Evidence-Based Treatment for Resectable Gastric Adenocarcinoma. J Gastrointest Surg 2021;25:36-47. [PMID: 33201456 DOI: 10.1007/s11605-020-04868-0] [Reference Citation Analysis]
20 Chakrabarti J, Koh V, Steele N, Hawkins J, Ito Y, Merchant JL, Wang J, Helmrath MA, Ahmad SA, So JBY, Yong WP, Zavros Y. Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids. Cancers 2021;13:6158. [DOI: 10.3390/cancers13246158] [Reference Citation Analysis]
21 Wu F, Sun D, Liao Y, Shang K, Lu C. RPL35A is a key promotor involved in the development and progression of gastric cancer. Cancer Cell Int 2021;21:497. [PMID: 34535139 DOI: 10.1186/s12935-021-02199-x] [Reference Citation Analysis]
22 Sarriugarte-lasarte A, García-alberdi E, Gutierrez-grijalba O, Mifsut Porcel P, Fernandez Gómez-cruzado L. Escudo de Blumer: signo diagnóstico de la diseminación a distancia del cáncer gástrico difuso. Rev Colomb Cir 2021;36:144-9. [DOI: 10.30944/20117582.547] [Reference Citation Analysis]